Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood
- 2015-09-15
- RCT · n = 109
- Pediatric Research 79(1)
- T. Taipale
- K. Pienihäkkinen
- E. Isolauri
- J. Jokela
- E. Söderling
- PubMed: 26372517
- DOI: 10.1038/pr.2015.174
- High evidence
The infants receiving BB-12 were reported to have experienced fewer respiratory tract infections (RTIs; 87 vs. 100%; risk ratio: 0.87; 95% confidence interval: 0.76, 1.00; P = 0.033) than the controls.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes